Basen and hyperglycaemia Patient Reports February 12, 2012

Basen Side Effects Report #5044138-7
Basen side effect was reported by a Consumer or non-health professional from JAPAN on May 29, 2006. Female patient, 77 years of age, weighting 110.2 lb, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with Basen. After drug was administered, patient experienced the following side effects: anti-insulin antibody positive, hyperglycaemia, hypoglycaemia. Basen dosage: .9 MG, QD. During the same period patient was treated with INNOLET, NOVORAPID, NOVOLIN R, ADALAT, BLOPRESS, ASPIRIN, MAGNESIUM. Patient was hospitalized. Patient recovered.

Basen Side Effects Report #5051151-2
Basen side effect was reported by a Consumer or non-health professional from JAPAN on May 29, 2006. Female patient, 77 years of age, weighting 110.2 lb, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with Basen. After drug was administered, patient experienced the following side effects: anti-insulin antibody positive, hyperglycaemia, hypoglycaemia. Basen dosage: .9 MG, QD. During the same period patient was treated with INNOLET, NOVORAPID, NOVOLIN R, ADALAT, BLOPRESS, ASPIRIN, MAGNESIUM. Patient was hospitalized. Patient recovered.